A new clinical trial from Engage Therapeutics might be right for you.
Print out this handout to give to your health care provider.

What is this study about?

StATES is looking at how effective and safe orally-inhaled alprazolam (also known as STAP-001) is in people 18 years of age or older with focal or generalized epilepsy when given at the time of a seizure episode.

The following information will be gathered for each seizure episode and in the hours after the STAP-001 medication is given:

  • If seizure activity was stopped within two minutes of giving STAP-001
  • If seizures recurred within 2 to 12 hours after giving STAP-001
  • The seizure severity
  • If the seizure progressed to a complex partial (focal impaired awareness) or generalized tonic-clonic seizure

Participating in StATES will take place partly at an inpatient unit in a hospital. Participants will be admitted to a Clinical Research Unit (CRU) or an Epilepsy Monitoring Unit (EMU) for 2 to 8 days for the “treatment phase.” When they are hospitalized, they will be givin a one-time dose of either the study drug (STAP-001) or a placebo treatment after a seizure takes place. The rest of StATES is done after the person is discharged from the hospital.

Study Overview

Patients included in this study:

  • Age 18 years or older
  • Diagnosis of focal or generalized epilepsy
  • Documented history of predictable seizure episodes, that include at least one of the following:
    • Generalized seizure episodes that start with a flurry of absence seizures or myoclonic seizures that last at least 5 minutes
    • Episodes of prolonged focal seizures that last at least 3 minutes
    • Episodes of multiple (2 or more) focal seizures within a 2-hour time period
  • Able to provide personally signed and dated informed consent to participate in the study or will have a legally authorized representative sign the informed consent on their behalf

Study Duration

  • StATES is about 8 to 12 weeks long, including the screening and follow-up periods.

Enrollment is completed. Awaiting study results.